A trial of induction Talazoparib followed by a combination of Talazoparib and Avelumab in advanced breast cancer: The TALAVE study

Heeke, AL; Pishvaian, M; Wang, HK; Cohen, A; Schlom, J; Donahue, R; Jochems, C; Gatti-Mays, M; Pohlmann, P; Tan, A; Isaacs, C; Lynce, F

CANCER RESEARCH, 2020; 80 (4):